Close Icon We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By continuing to use the website, you consent to our use of cookies.

Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC

This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Products:

Pharma Consulting

Close Icon

Hot topics

Thought leadership

Research and development strategy

Close Icon

Events

Conferences 2019

Awards

Upcoming Webinars

Webinar recordings

Close Icon

Global Search Configuration

Search Site Products & Services
Close Icon

Search by Keyword

Focus
Needs

September 2019 - Vascular Awareness Month

Learn More

Manufacturing Challenges Facing Cell and Gene Therapy

Webinar: Manufacturing Challenges Facing Cell & Gene Therapy

QIDP: Seven Years On, What Have We GAINed?

Download Report

Webinar: The Digital Health Revolution, Business Trends, Regulations, And More

Corporate Strategies of the biggest Generics and Biosimilar players

Corporate Strategies: Your insight to the strategies of the biggest Generics and Biosimilar players

Download Report

Personalised Medicine: The present landscape in numbers

View Infographic

In Vivo: The latest trends and the barriers in personalised medicine

View Report

Welcome to your Pharma Intelligence advantage

Market intelligence

We’re the world’s leading provider of drug, device, company, clinical trial and market intelligence in the competitive pharma and medtech markets.

News and insight

We provide unrivalled and daily-updated global insight, drawn from extensive authoritative data sets and enriched by human validation.

Data and analytics

Our premium quality data is drawn from 42,000 companies, 248,000 clinical trials in 175 countries and 65,000 drugs for 1,400 diseases.

Consultancy

Our bespoke clinical, commercial and market access solutions are designed to help you make smarter decisions that bring a better return on investment.

Global industry experts

Working in an interconnected global network, our 65 journalists and over 300 in-house analysts supply comprehensive analysis and reports.

Trusted partnerships

We’re the trusted partner of more than 3,000 companies including the top 50 pharma firms and top 10 contract research organizations.

Gold-standard service

Our customer services team will support you every step of the way so that our insight, intelligence and bespoke solutions match your needs.

Tailor-made solutions

From single reports and data downloads to enterprise subscriptions to custom consultancy, we can base our precise solutions round your exact needs.

Our Specialties

Clinical trial intelligence

Gain a competitive edge with comprehensive clinical trial intelligence. Find out what competitors are doing in key areas, understand regulations, view clinical trial and program timelines, identify sites and investigators.

Competitive and market intelligence

See the entire global biopharma and medtech market landscape in one place – our expert analysis and trusted databases cover all sectors of the industry.

business development licensing pharma intelligence

Business development and licensing

Get coverage of the latest pharmaceutical business developments, and historical metrics on financing, licensing, partnership, and acquisition.

business portfolio strategy pharma intelligence

Pharmaceutical portfolio strategy

Identify M&A targets and partnership opportunities, and develop business cases with our real-time intelligence, tools and analysis.

Regulatory approval

An increasingly complex regulatory framework for the pharmaceutical, biotech and medtech industries presents growing challenges to businesses. We’ll help you stay ahead.

medtech competitive intelligence pharma intelligence

Medtech market intelligence

To succeed in medtech, you need to have your finger on the pulse – we’ll help you access the accurate, reliable information you need.

View more
View Less

Our trusted Pharma Intelligence brands

Generics Bulletin

Corporate Strategies of the biggest Generics and Biosimilar players

17 Sep 2019

Understand the latest Corporate Strategies of the biggest Generics and Biosimilar players.

Topic Business strategies

Single report
In Vivo

Personalised Medicine: Treating the individual patient

17 Sep 2019

With more individualized treatments, such as cell and gene therapies, coming to market every day, In Vivo can keep you up to date on the diversity within clinical R&D, trials, the latest trends and the barriers that still exist within personalised medicine. We’ve pulled together information covering the increasing focus of personalized medicine in clinical R&D and the future trends of precision medicine.

Topic Personalized Medicine

Single report
In Vivo

In Vivo Personalised Medicine

16 Sep 2019

With more individualized treatments, such as cell and gene therapies, coming to market every day, In Vivo can keep you up to date on the diversity within clinical R&D, trials, the latest trends and the barriers that still exist within personalised medicine. We’ve pulled together a helpful infographic to summaries these changes.

Topic Personalized Medicine

View infographic
Scrip

Inclisiran’s Safety Data Suggest Game-Changing Potential In PCSK9 Market

By Joseph Haas 11 Sep 2019

The Medicines Co. unveiled Phase III safety data for inclisiran showing safety and tolerability comparable to placebo and efficacy in line with the PCSK9 inhibitor class – which should be the reassurance it needs for the oral agent.

Topic Drug development landscape Drug review

View article
Scrip

Interview: AstraZeneca’s Pangalos on Landmark DAPA-HF Resultsv

By Eleanor Malone 11 Sep 2019

AstraZeneca’s head of R&D spoke to Scrip about the outstanding results for dapagliflozin in heart failure regardless of diabetes status.

Topic Company analysis Diabetes

View article
Scrip

Anima Biotech Lighting The Way In Protein Translation

By Jo Shorthouse 10 Sep 2019

Emerging Company Profile: With a new partner in Eli Lilly, Anima Biotech and its disruptive technology that controls protein translation is starting to make waves as it urges the industry to see the light.

Topic Clinical trials

View article
Biomedtracker

Biomedtracker: Improved Custom Company Portfolio Feature

04 Sep 2019

Discover how creating custom company portfolios can help you overcome your toughest business challenges.

Topic Business strategies

Single report
Meddevicetracker

Meddevicetracker: New Company Portfolio Feature

04 Sep 2019

Meddevicetracker now gives you to the ability to find and follow partners or competitors and track their key activities. Quickly and easily identify new partners and keep tabs on your competition with the portfolio feature in Meddevicetracker.

Topic Business strategies Company analysis

Single report
Generics Bulletin

Executive and market moves interviews for exclusive insider knowledge

04 Sep 2019

Get in the side track on the Generics market with executive and market-moves interviews for exclusive insider knowledge.

Topic Business strategies

Single report
Datamonitor Healthcare

Reimbursement and Payer Management of Immune Checkpoint Inhibitors

03 Sep 2019

As immune checkpoint inhibitors continue to gain approvals in expanded patient populations, payers express concern surrounding the potential budget impact of the drug class. Considering the high costs of these treatments in comparison to standard chemotherapy, HTA and reimbursement agencies stress the requirement for solid survival data and highlight that price will be a major factor during negotiations

Topic Drug review

Single report
Citeline

QIDP: What have we GAINed?

By Jonathan Slater 02 Sep 2019

The Generating Antibiotic Incentives Now (GAIN) Act passed into law on July 9, 2012. Seven years on, we review the drugs that have obtained QIDP status, the companies involved, and the clinical trial landscape.

Topic Drug development landscape Drug review

Single report
In Vivo

Six of the Greatest Therapeutic R&D Challenges

23 Aug 2019

Explore the six biggest therapeutic R&D challenges facing the industry today with a free infographic from In Vivo. This snapshot view of the major issues facing R&D is packed with data and insights about everything from drug resistance to diagnostics challenges.

Topic Drug development landscape

View infographic
Medtech Insight

Compliance Corner: 2 FDA Compliance Branch Heads Talk Regulatory Meetings – And What You Can Expect

By Shawn M. Schmitt 23 Aug 2019

US FDA Compliance Branch directors Gina Brackett and Melissa Michurski shed light on the agency's use of regulatory meetings. The FDA has been pulling enforcement punches in recent years, relying more on holding the face-to-face meetings than sending warning letters.

Topic Policy and regulation

View article
Medtech Insight

Updates On The European Commission’s Medtech Agenda And Deadlines For The Rest Of 2019

By Amanda Maxwell 23 Aug 2019

The European Commission updates its rolling plan on progress with key document and structures toward implementation of the new medtech regulations every few months. What is new and what is still to come this year?

View article
In Vivo

In Vivo Content - Relied Upon by Senior Decision Makers

21 Aug 2019

There are many ways to market your brand and establish your business as a thought leader - but none of these methods compare to the distinct advantage gained through marketing with In Vivo and Informa Pharma Intelligence. The articles, news and interviews we feature are used daily by senior decision-makers to support their decisions, and to keep abreast of what their competitors are doing.

Topic Business strategies Medtech

Single report

Latest headlines

Medtech Insight

17 Sep 2019

Warning Letter Roundup & Recap – 17 September 2019

Link
Scrip

17 Sep 2019

Novartis’ Takes Piqray To India With Affordability Pledge

Link
Scrip

17 Sep 2019

Bucking Biosimilar Threat, Roche Sees Further Growth

Link
Pink Sheet

17 Sep 2019

Second Chance For Roche’s Polivy At CHMP

Link
Medtech Insight

17 Sep 2019

QUOTED. 17 September 2019. Ardy Arianpour.

Link
Scrip

17 Sep 2019

Acceleron Ends ACE-083 FSHD Testing After Phase II Failure

Link
Pink Sheet

17 Sep 2019

NICE Tackles Antibiotic Resistance In New UK Guidance

Link
Medtech Insight

16 Sep 2019

China Widens MAH Scheme To Medtech As Consumables Face Price Cuts

Link
Pink Sheet

16 Sep 2019

EU Court Advances Understanding Of SPC Patent Puzzle

Link
Scrip

16 Sep 2019

Amplyx Cleared To Complete Phase II Study Of New Antifungal Class

Link
Pink Sheet

16 Sep 2019

Will Purdue Bankruptcy Filing Resolve 'Unrelenting Chaos' Of Opioid Litigation?

Link
Scrip

16 Sep 2019

Purdue Pharma: From Blockbuster Success To Bankrupt Villain

Link
Pink Sheet

16 Sep 2019

Canada’s Drug Pricing Reform Faces Legal Challenge

Link
Pink Sheet

16 Sep 2019

US FDA Struggles To Meet Goals As Drug Sponsors' Meeting Requests Rise

Link
Medtech Insight

16 Sep 2019

Abbott And Sanofi To Connect Diabetes Technologies

Link

Featured products

Trialtrove: gold standard clinical trials intelligence

Trialtrove is the go-to resource for clinical trial research. Easily track your competitors' clinical R&D activity with expert insights and continually monitored trials.

Key benefits:

Curated by experts
Clinical trial landscape view
Ask-the-Analyst™

Datamonitor Healthcare: data analysis and insight

Datamonitor Healthcare's expert coverage of key diseases, companies, drugs and market trends makes it the go-to product for pharmaceutical and biotechnology companies to support the development and validation of their strategic plans and commercial decisions.

Key benefits:

Prioritize market opportunities
Identify unmet needs
Make informed decisions

Scrip: industry news and insights

Key benefits:

Follow market developments
Go beyond the news
Hear from news makers

Upcoming events

Webinar

Manufacturing Challenges Facing Cell & Gene Therapy

Presenters:

Amanda Micklus

USA

Awards

Medtech Insight Awards

Massachusetts , USA

Industry conference

MedTech Conference 2019

View All Events

Next steps

Request a live demo

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Request a free demo

How can we help you?

Our team is always happy to hear from you. Please call us at:

US Toll-Free : +1 888 670 8900
US Toll : +1 908 547 2200
UK & Europe : +44 (20) 337 73737
Australia : +61 2 8705 6907
Japan : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

September 2019 - Vascular Awareness Month

Webinar: Manufacturing Challenges Facing Cell & Gene Therapy

QIDP: Seven Years On, What Have We GAINed?

Webinar: The Digital Health Revolution, Business Trends, Regulations, And More

Corporate Strategies: Your insight to the strategies of the biggest Generics and Biosimilar players

Personalised Medicine: The present landscape in numbers

In Vivo: The latest trends and the barriers in personalised medicine

Welcome to your Pharma Intelligence advantage

Below are the Feature List

Market intelligence

News and insight

Data and analytics

Consultancy

Global industry experts

Trusted partnerships

Gold-standard service

Tailor-made solutions

Our Specialties

Pharma Intelligence latest insights

Latest headlines

Featured products

Below are the Product Brand List

Trialtrove: gold standard clinical trials intelligence

Datamonitor Healthcare: data analysis and insight

Scrip: industry news and insights

Upcoming events

Manufacturing Challenges Facing Cell & Gene Therapy

Medtech Insight Awards

MedTech Conference 2019

Keep up to date

Next steps

This is Contactus Section

Request a live demo

How can we help you?

Pharma Report Store